Hardy-Werbin, Max

Real-world data on T-DM1 efficacy - results of a single-center retrospective study of HER2-positive breast cancer patients. [electronic resource] - Scientific reports 09 2019 - 12760 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study

2045-2322

10.1038/s41598-019-49251-5 doi


Adult
Aged
Breast Neoplasms--drug therapy
Disease-Free Survival
Female
Humans
Maytansine--administration & dosage
Middle Aged
Receptor, ErbB-2--metabolism
Retrospective Studies
Survival Rate
Trastuzumab--administration & dosage